// App-Quantinova.ai

239 : Circulating tumor cells (CTCs) as a predictor of metastatic disease in patients with biochemical recurrence (BR) of prostate cancer with equivocal scan results.

Researchers

Presenter

  • Jeanny B. Aragon-Ching

Principal Investigators

  • Samuel J. Simmens

  • Steven R. Patierno

  • Robert S. Siegel

Medical Centers

  • Georgetown University Medical Center, Washington, DC

  • Georgetown University, Washington, DC

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Prostate cancer

Biomarkers

  • Circulating tumor cells

  • Prostate specific antigen

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved